FUTURE — SELL IBULHSGFIN 187.50 TARGET 181-168 SL PAID. With the latest stake sale, the company has raised a total of Rs2,670cr as fresh equity in the month of September, October and November 2020.
BUY BANKNIFTY 29300 PE 350 TARGET 510-740 SL PAID
BUY BANKNIFTY 29300 PE 350 TARGET 510-740 SL PAID
Nifty and Bank Nifty futures have witnessed healthy rollovers to the December series, with more long positions being carried over, according to analysts. Nifty futures saw a rollover of 77 per cent, much higher than last month’s 70-71 per cent; Bank Nifty rollovers remained firm at 78 per cent, the same as last month’s.
GOLD TECHNICAL ANALYSIS : Gold Prices Slide as US Political Uncertainty Eases – GSR
Gold Technical Analysis : Gold prices down through long-standing range Resistance level $1854——$1865, Seemingly setting their sights on a retest of former support in the $1752——$1770 Level. A breach below that may see prices probe under the $1700 Level. Alternatively, a bounce back above $1865 eyes the 1913——$1935 Region Next.
Spot Gold Drop Accelerated By Vaccine News, Positive U.S. Data – GSR
Spot Gold dropped to the lowest since July as positive vaccine news, strong economic data and the start of U.S. President-elect Joe Biden’s formal transition undermined the metal’s haven appeal.
Gold Silver Tips Today – Silver MCX Below 59747 sell And MCX Gold Below 48580 Sell 500—1000 For Target PAID
Gold Silver Tips Today – Silver MCX Below 59747 sell And MCX Gold Below 48580 Sell 500—1000 For Target PAID Stop Loss PAID
Gold Spot Below $1854 Next Target $1780——$1744 — Neal Bhai Reports
Gold Spot (XAU/USD) looks to threaten $1800 level amid coronavirus vaccine optimism after the yellow metal resumed last week’s bearish momentum on Monday and fell 2% to the lowest levels in four months at $1831.
Gold Extends Drop on Vaccine, Signs of Improving U.S. Economy
Gold fell to a four-month low as growing optimism over a coronavirus vaccine and signs of a increasing momentum in U.S. economic growth stifled demand for the metal as a haven.